Notably, NCAM-positive tumors, particularly neuroblastomas, exhibited significant tumor accumulation and tumor growth inhibition after the application of this radioimmunoconjugate (RIC) [21,22]. The gene discussed is NCAM1; the disease is neuroblastoma.